Coronavirus patients rush to join studies of Gilead drug
Ran in media outlets nationwide including The New York Times.
Coronavirus patients around the world have been rushing to join remdesivir studies that opened in hospitals in the last few weeks. … At the University of California, Irvine, Dr. Alpesh Amin has enrolled several patients. All are getting standard care even if they wind up getting a placebo rather than remdesivir, Amin said.